The Elekta Stereotactic Body Frame (SBF) is a device which allows extracranial targets to be localized and irradiated in a stereotactic coordinate system. Errors of positioning of the body relative to the frame are indirectly estimated by image fusion of multiple CT scans. A novel repositioning methodology, based on neurosurgical Stealth technology, is presented whereby accurate patient repositioning is directly confirmed before treatment delivery.
Introduction

Stereotactic Radiotherapy
Stereotactic radiotherapy is a treatment paradigm which improves accuracy of tumor targeting. In classical radiotherapy targeting, tumors are localized indirectly by visualization of bony landmarks. Stereotactic radiotherapy defines the tumor's vector position in three-dimensional stereotactic space. This process disarticulates the tumor from bony anatomy and potentially removes the limitations inherent to simulation films and portal images. Stereotactic radiotherapy theoretically allows for more precise localization of tumors and other targets of interest, allowing improved dose conformality as well as dose escalation while respecting surrounding tissue tolerances.
The stereotactic concept, which originated from neurosurgical principles, has been successfully applied to radiosurgery and fractionated radiotherapy. The classic example is the Leksell Gamma Knife (Elekta Instrument AB, Stockholm, Sweden), which uses an invasive neurosurgical headframe to fix and reference the head with its essentially immobile contents in stereotactic space (1, 2) . The same methodology has been applied to linear-accelerator radiosurgery (3). Noninvasive systems have been utilized for fractionated stereotactic radiotherapy and more recently have been reported for single-dose radiosurgery (4). Similarly, stereotactic techniques have been in use in the neurosurgical operating room (OR) for years. Framebased systems have existed for decades and, more recently, frameless systems have been devised which allow precise intraoperative navigation. One such frameless system, the Stealth Station (Medtronic Sofamor Danek, Minneapolis, MN 55432) is employed in many neurosurgical ORs. A variation of the Stealth Station software, developed with a different fiducial set, is the current Varian Radiocam system, sold commercially to Radiation Oncology departments for patient positioning. In the Stealth Station version, the patient first undergoes a volumetric CT or MRI of the brain with fiducials. These fiducials are attached non-invasively to the head and are visible on the scanned image set. This volumetric image set is then loaded onto the workstation. The patient is taken to the OR where the head is rigidly immobilized in a head holding device after induction of general anesthesia. A reference arc is rigidly fixed to the headholder. This reference arc contains light emitting diodes (LEDs) which reflect light and are visible to a stereoscopic infrared camera attached to the Stealth workstation. Each successive fiducial is "registered" by first selecting it in the image set on the workstation and then identifying the fiducial to the camera using the passive Stealth probe. After each of up to ten fiducials is localized in this manner, the workstation calculates a stereotactic coordinate system of the patient's head from the volumetric scan. Using this Stealth technique, the neurosurgeon can navigate in stereotactic space by using the passive probe and touching the fiducial landmarks. The Stealth Station software correlates the fiducial positions in the volumetric scan with the infrared image from the stereo camera and reports an estimate of the "predicted" accuracy. This accuracy is related to the "fiducial localization error (FLE)" discussed by Fitzpatrick, et al. (5) . The FLE is similar to the "fiducial registration error" (root mean distance between the fiducials after registration) but is essentially independent of the fiducial configuration. The user can thus point to a location in the patient's brain during surgery, allow the computer to identify that point on the patient's image set, and be confident that the two correlate with an accuracy of better than one millimeter.
The Stealth Station software might not be readily available for use in a Radiation Oncology setting. However, the commercially available Radiocam system from Varian is a Radiation Oncology product and could potentially be adapted for this use with the Stereotactic Body Frame. There are other commercial systems available with IR positioning and IGRT capabilities.
Extracranial Stereotactic Radiotherapy
Stereotaxis is not limited to intracranial sites. The Elekta Stereotactic Body Frame (SBF) (Elekta Oncology Systems Ltd., Crawley, United Kingdom) is a device which allows extracranial targets to be localized and irradiated stereotactically. The SBF consists of a combination of positioning and immobilization devices coupled to a stereotactic coordinate system translatable to virtual space in most commercial and in-house radiotherapy treatment planning systems. At the time of treatment, alignment of the patient to the treatment isocenter is done utilizing the positioning coordinates on the exterior of the SBF, shown in Figure 1 .
Proper repositioning of the patient in the SBF is critical to the treatment procedure. Uncertainties in the repositioning process are essentially two-fold: matching the position of the patient in the SBF to the simulation setup, and motion of the tumor within the fixed body. Tumor motion within the accurately positioned body (i.e. target motion along a vector in stereotactic space) can be reasonably well predicted from the published literature and through intelligent use of existing imaging modalities. Discussions of the tumor motions have been addressed by other authors and the inventors of the frame and will not be addressed here (6-9).
The repositioning uncertainty can be further broken down into two components which can each independently add to setup error: registration of the frame to the treatment linear accelerator; and secondly, repositioning of the body in the SBF. The registration of the SBF to linac is normally verified by the room lasers and is subject to standard quality control protocols. The second aspect, reproducible positioning of the patient within the SBF, however, is a source of potential error and is significantly more difficult to eliminate. Current SBF methodology recommends that patients be scanned by CT in the SBF for treatment planning, followed by another scan at the time of treatment. Fusion of the two studies is then used to predict daily setup errors on the treatment machine. This method is labor-intensive, expensive, and serves only to describe error, not reduce it. Set-up accuracy under optimum conditions ranges from 2.2 mm to 3.9 mm and target reproducibility ranges from 3.3 mm to 4.4 mm. This has been mathematically shown to require a security margin of 5 mm around a target (9).
At our institution, we have developed a novel repositioning methodology, which is based on established neurosurgical Stealth technology. Since the Stealth Station measures the position of fiducials relative each other, we place fiducials on the frame and on the patient. Thus, we can confirm patient position relative to the SBF. A check of the patient position in the SBF is performed on the linear accelerator immediately before treatment delivery and permits rapid (ca. 5-10 minutes) verification of the relationship of the patient's body to the stereotactic frame with sub-millimeter accuracy. This procedure theoretically eliminates the need for a second scan and minimizes the setup error between the treatment planning scan and subsequent realignment on the treatment linac.
Materials and Methods:
All imaging was performed on a Marconi PQ5000 CT simulator (Marconi Medical Systems, Inc., Cleveland, OH 44143). Initially, phantom studies were done using a radiotherapy simulation phantom (Radiology Support Devices, Inc., Long Beach, CA 90745) with an internal skeleton and visible internal organs. The phantom was placed in the SBF and positioned according to the described methodology, utilizing a vacuum-lock bag attached to an insert and laser positioning marks which were placed on the chest and on the legs just below the patellae. Later, actual patients were simulated in the same fashion. For the patient studies, the abdominal compression paddle was used to limit the tumor motion due to respiration in the patients that could tolerate it. For each phantom/patient simulation, a set of stereotactic fiducial markers used for Stealth craniotomy was placed on the SBF and on the phantom/patient's chest. The phantom/patient and frame were imaged to obtain a volumetric CT scan of 3mm slice thickness with 3 mm spacing as required by the Stealth Station software. The images were then transferred via the hospital DICOM network to the Stealth station. An imaging 3D model was built with a threshold that included the fiducial markers. Once the fiducials were seen on the 3D model, those fiducials were selected as reference points. For the patient studies, the fiducials were placed on the patient in areas with limited motion due to respiration (sternum, lateral rib cage, iliac spine). Additionally, at the time of fiducial registration, the patient was instructed to hold their breath. A Stealth reference arc was attached to the stereotactic body frame, and the fiducials were registered between the CT dataset and the patient, as shown in Figure 2 .
The phantom was used to simulate actual patient conditions: once with the phantom's chest elevated (to simulate normal excursion with breathing); and once after the phantom's thorax and arms had been lifted out of the frame, the phantom slid down several centimeters, and then dropped into the frame inaccurately (to simulate the non-compliant mobile patient). Human patients were removed from the SBF and allowed a rest period. The phantom/patient was then repositioned using the SBF's laser positioning system. Using the surgical navigation system, the setup error from the original planning position was quantitatively measured by fiducial localization, adjusting the patient position to minimize the measured error. A confirmatory CT scan was performed, and the resulting image set was registered to the initial scan to verify identical positioning. A treatment isocenter was automatically placed at the center of the contoured GTV, as determined by the Pinnacle treatment planning software (Philips Medical Systems, Milpitas, CA 95035). To determine the effect of reducing the setup error between to the two scans, the GTV was contoured on each of the CT datasets. The distance between the two isocenters was measured to determine the actual shift in the tumor position when the patient was repositioned in the SBF.
The image fusions done in the phantom and patient studies were performed in the Pinnacle treatment planning software using mutual image information. Image translations and rotations were done by hand, with final fusion approval determined by visual inspection of the frame.
Results
Phantom Studies
The stereotactic Stealth system rapidly provided several pieces of information. First, a FLE accuracy of 0.5 mm was obtained with the initial registration. This error is the baseline accuracy expected with defining the fiducial positions in the CT dataset. Additionally, when the phantom was clearly misaligned, producing a large setup error, the system rejected the fiducial localization. Finally, after the phantom was optimally aligned using the SBF's laser system, the Stealth Station reproducibly confirmed a 0.6 mm accuracy of phantom-SBF alignment. The Stealth station also displays the accuracy of alignment within nested spheres surrounding the stereotactic isocenter, as shown in Figure 3 . Our method achieved an uncertainty of no greater than 2 mm over the entire field of view of the CT scan, and of no greater than 1 mm over the area of interest within the phantom.
In order to compare the Stealth method of direct error determination to the indirect method of estimating error by repeat CT scans, the confirmatory CT scans of the phantom were fused to the initial treatment scan by three different available fusion methodologies: manual overlays; point matching; and volume matching. This fusion, which represents the recommended standard for predicting setup error, was able to provide no better than 2 mm accuracy. Additionally, a reference fiducial was confirmed to give an identical localization through the AcQSim within 1mm in the X and Y dimensions. Since the body frame is not indexed to the table at this time, confirmation along the Z axis could not be confirmed with the AcQSim software. The error in the Z axis was estimated to be less than 3mm, the slice thickness of the CT dataset.
Patient Studies
Four extracranial radiosurgery patients with lung metastases were simulated using the Stealth Station procedure as part of the repositioning process. The data in Table I show that the Stealth Station reports very small FLE errors in the fiducial positions due to shifts in the patient fiducials relative to the frame fiducials for each of these patients. As determined by the image fusions, reduction of the repositioning errors demonstrated that shifts in the GTV isocenters for these patients due to internal organ motion were on the order of only a few millimeters.
Discussion
Phantom Studies
The phantom studies using the Stealth Station software demonstrated the feasibility of using this procedure for position verification in extracranial Stereotactic radiosurgery. This methodology gives directly verifiable setup accuracy of the patient in the treatment position as good as or better than the indirect method of repeat CT scans. Table I shows the shift in the GTV isocenter in patients between the initial and the repositioned scans. Several conclusions can be drawn from these data. As mentioned earlier, uncertainties in the repositioning process include both (i) errors that reflect the result of matching the position of the patient in the SBF to the simulation setup, and (ii) errors that result from motion of the tumor within the fixed body. Shifts in the GTV position can include both of these types of errors. The Stealth Station alignment helped to minimize errors of type (i). Using the Stealth Station procedure for realignment, the remaining shifts in the GTV positions due to errors of type (ii) were on the order of a few millimeters. For patients that can tolerate it, an abdominal compression pad may be used to help limit the tumor motion (ii). Table I shows that Patient 4 had a small RMS fiducial error, but a GTV shift much larger than those seen in the other 3 patients. In fact, the tumor in Patient 4 was located in the right lower lobe, very near the diaphragm. Additionally, this patient could not tolerate the abdominal compression pad, allowing much more tumor motion. The other 3 patients had tumors that were either located much higher in the thorax or were adhered to the chest wall, thus limiting the expected tumor motion. Compensation for tumor motion due to respiration must be included as part of the treatment plan by either allowing for the total tumor excursion in the defined GTV or by respiratory gating.
Patient Studies
Technical Issues
Several technical issues will need to be addressed in any department attempting to use this methodology in a routine fashion. Firstly, the optimum placement of the stereotactic fiducials needs to be determined. Since the relationship between patient and frame is essential, approximately an equal number of fiducials should be placed on the patient and on the SBF. For optimum realignment, spacing should be even over the entire volume of interest. For practical purposes, several concessions may be made. The Stealth Station permits a maximum slice thickness of 3 mm, which places practical constraints on the field over which fiducials can be placed, as the number of slices which can be downloaded into the treatment planning software may be limited by the individual user's system configuration.
For example, our system runs at less than optimum after 100-125 slices have been exceeded, due to the amount of memory installed on our workstations. Thus, a volume with an axial length of greater than 30 cm becomes impractical for our purposes. Since many patients may be expected to be treated with non-coplanar arcs, the user must ensure that any volume through which beams may pass must be included in the scan. This limitation may be overcome by performing two passes, one with 3 mm cuts for the Stealth station and one with 3 mm resolution near the target and 5 mm beyond that. For this work, 3mm slices were used because of the limitations of our older CT system to 3mm slices. In general, thinner slices would be preferable and would provide more accurate targeting with the finer resolution.
A more pressing constraint on fiducial placement is the field of view (FOV) for the scanner used. The maximum FOV is approximately 480 mm for our Marconi PQ5000, whereas the body frame is approximately 470 mm in diameter. Therefore, no Stealth Station fiducials can be placed outside of the body frame since these potentially may not show up in the scans. Additionally, due to the reliance on the internal fiducials of the frame there is great importance in perfect centering in the CT bore. It may thus be prudent to take a sample scan of the volume prior to the full data acquisition to ensure clear alignment. Other constraints on fiducial placement revolve around the practical need for the fiducial to be accessible to the Stealth Wand. Permanent touch points for the wand may be attached to the frame in a variety of fashions limited only by the user's access to a good machine shop. In addition, placement of fiducials on both scanner and machine tabletops themselves may be a consideration when confirmation along the Z-axis desired, or for that matter, when positioning patients using non-SBF methods.
For the Stealth Station fiducials, pitch may play an important role. Several authors have shown that a lower pitch yields a greater longitudinal resolution.(10-12) A lower pitch will invariably induce more breathing artifacts due to longer scan times, contributing to the patient placed fiducial uncertainty. Additionally, there will be an increased chance of tube overheating which would cause a break in the CT study for cooling. The default pitch of 1.75 was used in this study. An optimal pitch and slice spacing should be evaluated for this device that will maintain longitudinal resolution as well as minimize motion artifact.
Several authors have reported reproducibility studies on contouring of patient volumes on different RTP and image handling systems. (13, 14) Most of these studies found that the errors in reproducibility in contouring are on the order of a few millimeters, in the same range as the errors found here in the GTV isocenter shifts.
Lastly, the goal of this work was to improve the patient realignment process in the SBF. The availability of a Stealthstation workstation could limit the general use of this technique. However, the Varian Radiocam system was developed from the same software and is commercially available to Radiation Oncology departments. That system could potentially be adapted for this use for facilities that have both the Radiocam system and the Elekta SBF. We must acknowledge that as technology progresses, systems capable of cone beam CT and other IGRT methods will provide better realignment for stereotactic body radiation therapy cases, for centers that can afford and can support these systems. For SBF users, this realignment verification can improve targeting at the time of treatment.
Practical Concerns
With regards to clinical usefulness, direct Stealth localization provides a notable improvement over the traditional repositioning verification method. The Stealth technology can assist in determining the direction of inaccuracy. Once the user has registered the fiducial marker and an initial accuracy is established, one can navigate with the system by touching the markers on the patient and SBF to determine in which direction to move the patient. If the misalignment exceeds 5-6 mm, the center of the marker on the Stealth system and the actual probe will not line up. The clinician can then move the patient until the alignment occurs. Once alignment occurs, one can register the markers to the images and then again determine the accuracy. Successful use of this technique also eliminates the need for plain X-ray orthogonal isocenter views as recommended by some authors, an inherently inaccurate technique with an overall correlation of approximately 63% (range 33%-100%). Another advantage of this method is that it allows the clinician to take several days to calculate an optimum treatment plan. If the procedure is not performed on the same day as the scans are performed, the donut-shape of the fiducial allows for placement of a semi-permanent tattoo in the geometric center of each one. This method is preferable to using implanted fiducials, and allows for use of the SBF to deliver fractionated therapy.(15-16) Finally, if a patient's body habitus changes over the course of treatment and accurate alignment using Stealth becomes impossible, it is a simple matter to rescan and re-register the patient.
Stealth localization also theoretically assists in the process of treatment planning. The mathematical implications of having to deal with multiple inaccuracies in the optimization of determining the PTV have been described by Craig, et al., who suggest that uncertainties should be added in quadrate.(17) Their model suggests that systematic uncertainties below a threshold of 4 mm potentially have a small impact on tumor control probability. This threshold is usually exceeded using the traditional SBF setup method. The inventors of the SBF describe a reproducibility of 5-8 mm for 90% of patient setups in the lung and liver.(7,8) Wulf, et al., have shown a target reproducibility ranging from 3.3 mm to 4.4 mm; however when conventional port films are used, correlation to soft tissue targets is only 33%. (9) Herfarth, et al., suggest a median setup accuracy of up to 2.0 mm (range 0.3-5.0 mm) with a median target shift of up 2.3 mm (range 0.0-7.0 mm) but with repositioning required in two thirds of patients.(6) Since our method reduces one of the components of setup error to below 1 mm, that particular component of uncertainty theoretically no longer needs to be added into the PTV equation and only motion of the target within the body becomes the determining variable. This serves to simplify the dosimetric planning process, especially in the context of biologic optimization of treatment planning as described by Brahme, et al.(18) 
Conclusion
The work in this study found that the neurosurgical Stealth Station software could be used to minimize patient repositioning errors in the Elekta Stereotactic Body Frame. This methodology gives directly verifiable setup accuracy as good as or better than the indirect method of estimation from repeat CT scans. The Stealth method thus effectively eliminates one of the variables which add uncertainty to any extracranial radiotherapy procedure, potentially simplifying treatment planning and optimization. This additional confirmation of the patient position is clinically useful, particularly in the large dose fractions given in Extracranial Stereotactic Radiosurgery.
